MedTrace Logo

Pregnancy Cohort Study: Pregnancy as a Window to Future Health

NCT06925815 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2026-04-13

No results posted yet for this study

Summary

The goal of this observational cohort study is to gain deep insights into how metabolic disorders such as obesity or diabetes during pregnancy affect the metabolic and cardiovascular health of mother and child in the short and long term.

It will investigate the following questions:

* How do maternal metabolic disorders affect pregnancy outcomes?
* How do maternal metabolic disorders affect fetal growth?
* How do maternal metabolic disorders affect the newborn's metabolism and body composition?
* How do maternal metabolic disorders during pregnancy affect breast milk composition?
* How do maternal metabolic disorders during pregnancy affect the metabolic health of the mother after birth? Participants in this study are pregnant women who will be asked to come to the clinics for three visits during their pregnancy, as well as for the delivery of their baby, and one time 2-3 months thereafter. At each visit, researchers will perform physical examinations (such as body composition measurements) and collect biological samples (blood, urine, saliva), clinical information, and lifestyle data. At birth, researchers will collect cord blood and breast milk as well as clinical data of the delivery and the health of the baby. Researchers will measure body fat in newborn babies and at 2-3 months of age.

Conditions

  • Healthy Pregnant Women
  • Obese Pregnant Women
  • Gestational Diabetes

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Evelyn Jantscher-Krenn, PhD · Medical University of Graz

  • Herbert Fluhr, Univ.-Prof. Dr. med. · Medical University of Graz

  • Ursula Hiden, Assoc. Prof. · Medical University of Graz

  • Christina Stern, Dr. med. · Medical University of Graz

  • Federica Piani, MD, PhD · Medical University of Graz

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-27
Primary Completion
2033-06-30
Completion
2034-06-30

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06925815 on ClinicalTrials.gov